Key result
Guideline-directed lipid-lowering therapy remains widely underutilized in patients with peripheral arterial disease.
Answers are grounded in this paper and cite their sources.
There is a critical need for implementation strategies to improve the underutilization of guideline-directed lipid-lowering therapy in patients with peripheral arterial disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bolden et al. (2026) conducted a review in Peripheral arterial disease (PAD). Lipid-lowering therapy was evaluated. Guideline-directed lipid-lowering therapy remains significantly underutilized in patients with peripheral arterial disease, highlighting an urgent need for multifaceted implementation strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: